PAYER POLICY CHANGES

J0577 Insurance Policy Changes

HCPCS J0577 is officially defined as "Injection, buprenorphine extended-release (brixadi), less than or equal to 7 days of therapy." HCPCS J0577 is referenced in 5 tracked payer policy changes from Maryland Medicaid, Oregon Health Plan, and 1 other payer. For billers and coders, staying current on payer-specific coverage criteria, reimbursement rules, and prior-authorization requirements for HCPCS J0577 is critical to clean claim submission. Each entry below links to the full policy analysis with effective dates and action steps.

Watch J0577

Get one email when a payer policy names J0577, a payer adds or drops it from a prior auth list, or Medicare changes its NCCI pairs, unit limit, payment or coverage articles.

No account needed. We send a confirmation link first, and every email has a one-click stop link.

See every payer rule for J0577

Prior authorization lists, coverage criteria, NCCI edits and Medicare coverage articles for J0577 in one place.

Get alerts for changes like this

Save a search and get email alerts when a new policy change matches your filters: daily or weekly, your choice, on every plan.